Can a clinically stable adult with a 2 mm distal ureteral stone, moderate hydronephrosis, no infection or renal impairment, and no major comorbidities (uncontrolled diabetes, coagulopathy, severe cardiac disease) be safely discharged?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Discharge Someone with a 2mm Distal Ureteral Stone and Moderate Hydronephrosis?

Yes, a clinically stable adult with a 2mm distal ureteral stone and moderate hydronephrosis can be safely discharged with medical expulsive therapy, appropriate pain control, and close outpatient follow-up, provided there is no evidence of infection, uncontrolled pain, or renal impairment. 1, 2

Key Discharge Criteria That Must Be Met

Your patient must satisfy ALL of the following before discharge is appropriate:

  • Well-controlled pain with oral analgesics (NSAIDs as first-line) 1, 3
  • No clinical evidence of sepsis (no fever, normal or stable leukocytosis, negative signs of systemic infection) 1, 2
  • Adequate renal functional reserve (stable creatinine, no acute kidney injury) 1
  • Ability to tolerate oral intake and maintain hydration 2
  • Reliable follow-up available within 2-4 weeks 2

Why This Stone Has Excellent Prognosis

A 2mm distal ureteral stone has a very high spontaneous passage rate (stones ≤5mm have approximately 62-65% passage rate, with smaller stones having even higher rates). 2, 4 Most stones that pass spontaneously do so within approximately 17 days (range 6-29 days). 2, 4

The moderate hydronephrosis, while notable, does not contraindicate discharge in a stable patient. Research shows that moderate hydronephrosis is associated with only slightly higher passage failure rates (28%) compared to mild hydronephrosis (20%), and is not strongly predictive of need for intervention in small stones. 5 Severe hydronephrosis would be more concerning and warrant closer monitoring or earlier urologic referral. 5

Discharge Management Plan

Pain Control

  • NSAIDs (diclofenac, ibuprofen) are first-line for renal colic 2, 3
  • Use at the lowest effective dose, particularly with eGFR considerations 2
  • Opioids should be reserved as second-line only when NSAIDs are contraindicated or insufficient 2, 3

Medical Expulsive Therapy

  • Alpha-blockers (tamsulosin 0.4mg daily) should be prescribed to facilitate stone passage 2, 3
  • Counsel the patient that this is off-label use and discuss potential side effects (orthostatic hypotension, dizziness) 1, 3
  • Alpha-blockers show greatest benefit for stones >5mm in the distal ureter, but can still be beneficial for smaller stones 2, 3

Mandatory Follow-Up Imaging

  • Periodic imaging is required to monitor stone position and assess for worsening hydronephrosis 1, 2
  • Preferred modalities: low-dose CT or ultrasound 2, 3
  • Timing: within 2-4 weeks for routine follow-up, or sooner if symptoms change 2

Maximum Duration of Conservative Management

  • Do not exceed 4-6 weeks of observation from initial presentation 2, 4, 3
  • Prolonged obstruction beyond this timeframe risks irreversible kidney damage 4, 3

Red Flags Requiring Urgent Return or Intervention

Instruct the patient to return immediately or seek urgent urologic consultation if any of the following develop:

  • Fever or signs of infection (this becomes a urologic emergency with obstruction) 1, 2, 3
  • Uncontrolled pain despite adequate analgesia 2, 3
  • Inability to tolerate oral intake or maintain hydration 2
  • Anuria or significant decrease in urine output 3
  • Worsening symptoms suggesting progression of obstruction 2

When Intervention Becomes Necessary

If conservative management fails, intervention options include:

  • Ureteroscopy (URS): 90-95% stone-free rate in single procedure for stones <10mm, but more invasive 2, 4
  • Extracorporeal shock wave lithotripsy (ESWL): 80-85% success rate with lower morbidity, may require repeat procedures 2, 4

For a 2mm stone, intervention would rarely be needed unless complications develop. 2

Critical Pitfalls to Avoid

  • Do not discharge if there is any suspicion of infection in the setting of obstruction—this requires urgent decompression via ureteral stent or percutaneous nephrostomy 1, 3
  • Do not confuse "small size" with "low risk"—even a small stone can cause complete obstruction and severe complications if infection develops 2
  • Do not allow observation to extend beyond 6 weeks without reassessment, as this risks permanent renal damage 2, 4, 3
  • Do not use NSAIDs indiscriminately—use caution with reduced eGFR or active GI disease 2, 3

Outpatient Urology Referral

  • Non-urgent referral to urology is appropriate for stable patients with controlled symptoms 2
  • Referral should occur within 2-4 weeks for follow-up imaging and assessment 2
  • Urgent referral is necessary if red flags develop or if stone has not passed by 4-6 weeks 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Ureteral Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Medical Management of Ureteral Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of a 5 mm Renal Calculus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the management approach for a patient with hydronephrosis and hydroureter with no evidence of a stone?
What are the recommended evaluations and management for a 42-year-old female with a history of stress related to school, excessive chocolate consumption, and smoking (tobacco use), presenting with right flank discomfort and a heavy feeling, without symptoms of hypo/hyperglycemia, nausea, or vomiting, and with normal vital signs?
What is the best course of action for a 35-year-old female with a history of right renal (kidney) stone, who had a retained ureteral stent (indwelling catheter) that was removed, and now presents with severe right hydronephrosis (fluid accumulation in the kidney) and hydroureter (fluid accumulation in the ureter) without evidence of an obstructing stone on computed tomography (CT) scan?
What could be the cause of intermittent right lower quadrant abdominal pain in a 40-year-old male, which started after holding urine for 3 hours, is not severe, and does not affect urination, eating, or drinking?
What is the management for a 20-year-old patient with loin pain due to a 4mm ureteric stone?
Can quetiapine (Seroquel) be safely combined with methocarbamol?
In a woman with uterine adhesion to the anterior abdominal wall at a prior cesarean section scar, what is the risk of developing additional adhesions after future abdominal surgery and how should this be evaluated and managed?
What is the recommended starting dose of the Anoro inhaler (umeclidinium bromide 62.5 µg + vilanterol 25 µg) for adult patients with chronic obstructive pulmonary disease?
What evidence supports the health benefits of Moringa oleifera, what is the recommended daily dose, and what safety considerations or contraindications apply for patients with diabetes mellitus, those taking anticoagulant or antiplatelet therapy, pregnant or lactating women, and individuals with thyroid disorders?
What analgesic regimen is recommended for routine post‑coronary angiography discomfort?
Can an Indiba facial treatment be performed on a patient who is currently wearing an external cardiac monitor (e.g., Holter or telemetry)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.